• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

The benefit of patient-focused MTM services

Article

If the approach to medication therapy management (MTM) is flexible, integration of MTM services into the design of a health plan can impact plan performance and result in a positive return on investment.

If the approach to medication therapy management (MTM) is flexible, integration of MTM services into the design of a health plan can impact plan performance and result in a positive return on investment, according to Kevin Boesen, PharmD, chief information officer, SinfoniaRx, The University of Arizona, Tucson, Arizona.

Speaking at the Academy of Managed Care Pharmacy (AMCP) meeting in a session entitled Improved Measured Outcomes in MTM, Boesen emphasized the need for MTM services to help reduce medication misuse that results in considerable mortality and morbidity in patients and costs the healthcare system over $200 billion every year. In people with serious chronic illnesses, who account for the majority of healthcare spending, he highlighted that half are treated by 3 or more physicians and one-third use multiple pharmacies, which increases the complexity of their care and risk of medication misuse.

According to Boesen, mixed reports about the impact of MTM services may be due to their evaluation as a one-size-fits-all approach to MTM, when in reality the value of MTM is in their different approaches that work well in different environments. He talked about using different modalities to deliver MTM services tailored to the needs of the patient, including delivering  comprehensive medication reviews or brief targeting consultations via face-to-face, by telephone, or video conferencing, and by using other technologies such as texts or smart phone apps.

“MTM services delivered in a patient-focused fashion in a manner best for the patient will have an impact,” he said, emphasizing the potential for a dramatic impact on patient outcomes if medication misuse can be prevented and corrected.

For executives who are seeking to improve health and wellness in their health plans, MTM services integrated into a health plan is another way to accomplish this along with the current focus on other programs such as STAR ratings in Medicare, value-based contracting, and other pay-for-performance strategies.

Related Videos
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Related Content
© 2024 MJH Life Sciences

All rights reserved.